Latest filing published 03 May 2022 for Oxford Biomedica plc.
Filing timeline
BuySaleInsider track record
Jason Slingsby: trading record in brief
Jason Slingsby discloses dealings in Oxford Biomedica plc to RNS (LSE). We count 8 filings; the first trade dates from 7 June 2019 and the latest from 27 April 2022.
Sales make up the whole of the open-market record (4 sales, €306k). The rest of the record consists of 4 option exercises. In 2022 alone, the filings show no purchases and 1 sale.
The newest entry dates from 3 May 2022: an option exercise, in Oxford Biomedica plc. Between a trade and the moment it shows up on RNS (LSE), the median delay is 4 days. For comparison, UK MAR gives managers three business days to notify a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jason Slingsby
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,712 sharesOutside a trading venueISIN GB00BDFBVT43FCA-NSM:4357039-0
- 8,712 shares@ £5.3913.4% of flowLondon Stock Exchange, Main Market (XLON)ISIN GB00BDFBVT43FCA-NSM:4357039-1
- 1,584 sharesOutside a trading venueISIN GB00BDFBVT43FCA-NSM:4035837-0
- 1,584 shares@ £12.995.7% of flowLondon Stock Exchange, Main Market (XLON)ISIN GB00BDFBVT43FCA-NSM:4035837-1
- 13,393 shares@ £4.9717.5% of flowLondon Stock Exchange, Main Market (XLON)ISIN GB00BDFBVT43FCA-NSM:3724844-0
- 13,393 shares@ £8.4529.8% of flowLondon Stock Exchange, Main Market (XLON)ISIN GB00BDFBVT43FCA-NSM:3724844-1
- 12,014 shares@ £2.74726.5% of flowLondon Stock Exchange, Main Market (XLON)ISIN GB00BDFBVT43FCA-NSM:LSE20190610143455_14105226_20200326185129889_24695-0
- 12,014 shares@ £7.6073.5% of flowLondon Stock Exchange, Main Market (XLON)ISIN GB00BDFBVT43FCA-NSM:LSE20190610143455_14105226_20200326185129889_24695-1
8 of 8 declarations